Asia-Pacific Perspectives on the Role of Continuous Glucose Monitoring in Optimizing Diabetes Management
Year: 2023
Type: conference-abstract
Abstract: Diabetes is prevalent, and it imposes a substantial public health burden globally and in the Asia-Pacific (APAC) region. The cornerstone for optimizing diabetes management and treatment outcomes is glucose monitoring, the techniques of which have evolved from self-monitoring of blood glucose (SMBG) to glycated hemoglobin (HbA1c), and to continuous glucose monitoring (CGM). Contextual differences with Western populations and limited regionally generated clinical evidence warrant regional standards of diabetes care, including glucose monitoring in APAC. Hence, the APAC Diabetes Care Advisory Board convened to gather insights into clinician-reported CGM utilization for optimized glucose monitoring and diabetes management in the region. We discuss the findings from a pre-meeting survey and an expert panel meeting regarding glucose monitoring patterns and influencing factors, patient profiles for CGM initiation and continuation, CGM benefits, and CGM optimization challenges and potential solutions in APAC. While CGM is becoming the new standard of care and a useful adjunct to HbA1c and SMBG globally, glucose monitoring type, timing, and frequency should be individualized according to local and patient-specific contexts. The results of this APAC survey guide methods for the formulation of future APAC-specific consensus guidelines for the application of CGM in people living with diabetes.
Institutions: The University of Sydney, Royal Prince Alfred Hospital, Seoul National University, Seoul National University Bundang Hospital, Korea University Anam Hospital, Tianjin Medical University, Shanghai Jiao Tong University, Shanghai Sixth People's Hospital, Chinese University of Hong Kong, Khoo Teck Puat Hospital, University Malaya Medical Centre, University of Malaya, Chong Hua Hospital, Madras Diabetes Research Foundation, Dr. Mohan's Diabetes Specialities Centre, Baker Heart and Diabetes Institute, Peking University, Peking University People's Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,500
Funder: Abbott Diabetes Care
OpenAlex ID: W4378347694